Treatment for glioblastoma (GBM)
Intended for US audiences only.


In this section, you'll find a variety of resources to help you better understand Optune, share this novel treatment with your patients who have newly diagnosed or recurrent glioblastoma (GBM), and start prescribing Optune.

Long-term quality survival brochure

Long-term Quality Survival brochure

Learn about Optune + TMZ for patients with newly diagnosed GBM.

View this PDF
Incorporating Optune® Into Practice supplement

Incorporating Optune Into Practice supplement

Hear from a multidisciplinary panel of experts about incorporating Optune into your practice.

View this PDF
Optune® Educational presentation

Optune Educational presentation

Get an overview of Optune to help you manage patients with GBM.

View this PDF
Peer-reviewed publications

Peer-reviewed publications

Review various publications about Optune

See publications
Video library

Video library

Materials to help you become more familiar with Optune

Watch videos
Calendar of events

Calendar of events

Optune open houses and events focused on brain cancer

See upcoming events

Indications For Use

Optune is intended as a treatment for adult patients (22 years of age or older) with histologically-confirmed glioblastoma multiforme (GBM).